Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006

被引:58
作者
Trotter, Caroline L. [1 ]
Waight, Pauline [2 ]
Andrews, Nick J. [3 ]
Slack, Mary [4 ]
Efstratiou, Androulla [4 ]
George, Robert [4 ]
Miller, Elizabeth [2 ]
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England
[2] Ctr Infect, Hlth Protect Agcy, Immunisat Dept, London, England
[3] Ctr Infect, Hlth Protect Agcy, Stat Modelling & Econ Dept, London, England
[4] Ctr Infect, Hlth Protect Agcy, Resp & Syst Infect Lab, London, England
基金
美国国家卫生研究院;
关键词
Streptococcus pneumoniae; Invasive pneumococcal disease; Epidemiology; Meningitis; STREPTOCOCCUS-PNEUMONIAE; CHILDREN; ADULTS;
D O I
10.1016/j.jinf.2009.12.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To describe the epidemiology of invasive pneumococcal disease (IPD) in England & Wales in the pre-conjugate vaccine era. Methods: We analysed reports of culture-confirmed IPD submitted to the national surveillance system between July 1996 and June 2006. Results: The incidence of IPD was 10 per 100,000 overall, and increased over time. The typical pattern of IPD by age was observed, with the highest incidence in young children and older adults. There was little change in IPD incidence in the elderly, despite the widespread use of 23-valent pneumococcal polysaccharide vaccines since 2003. The distribution of serotypes changed over time; notably the proportion of cases caused by serotype 14 decreased, and the proportion due to serotype 1 increased. The incidence of meningitis was 0.6 per 100,000 overall, and as a proportion of all IPD cases was most common in children under 1 year of age (30%). Particular serotypes were significantly associated with a presentation of meningitis, after controlling for age and year, and the case: carrier ratio varied markedly by serotype. Conclusions: This paper provides a baseline for evaluating the impact of 7-valent pneumococcal conjugate vaccines, introduced in September 2006. Ongoing high-quality laboratory-based surveillance of IPD in all age groups is essential. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 50 条
  • [21] Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014
    Oligbu, Godwin
    Collins, Sarah
    Andrews, Nick
    Sheppard, Carmen L.
    Fry, Norman K.
    Slack, Mary P. E.
    Borrow, Ray
    Ladhani, Shamez N.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (07) : 1191 - 1198
  • [22] Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine
    Tam, Pui-Ying Iroh
    Madoff, Lawrence C.
    Coombes, Brandon
    Pelton, Stephen I.
    PEDIATRICS, 2014, 134 (02) : 210 - 217
  • [23] The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005-2019
    Oyewole, Oluwaseun Rume-Abiola
    Lang, Phung
    Albrich, Werner C.
    Wissel, Kerstin
    Leib, Stephen L.
    Casanova, Carlo
    Hilty, Markus
    MICROORGANISMS, 2021, 9 (05)
  • [24] Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation
    Levy, Corinne
    Varon, Emmanuelle
    Ouldali, Naim
    Bechet, Stephane
    Bonacorsi, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) : 446 - 454
  • [25] Impact of the 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Younger Than 90 Days in England and Wales
    Ladhani, Shamez N.
    Andrews, Nick J.
    Waight, Pauline
    Borrow, Ray
    Slack, Mary P. E.
    Miller, Elizabeth
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (05) : 633 - 640
  • [26] Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era
    Martin, Olufunke O.
    Moquist, Kristin L.
    Hennessy, Jane M.
    Nelson, Stephen C.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
  • [27] Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands
    Wagenvoort, Gertjan H. J.
    Sanders, Elisabeth A. M.
    Vlaminckx, Bart J.
    Elberse, Karin E.
    de Melker, Hester E.
    van der Ende, Arie
    Knol, Mirjam J.
    VACCINE, 2016, 34 (08) : 1077 - 1085
  • [28] Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
    Nikolova, Kristiana Alexandrova
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2021, 9 (10)
  • [29] Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use
    Pilishvili, Tamar
    Zell, Elizabeth R.
    Farley, Monica M.
    Schaffner, William
    Lynfield, Ruth
    Nyquist, Ann-Christine
    Vazquez, Marietta
    Bennett, Nancy M.
    Reingold, Arthur
    Thomas, Ann
    Jackson, Delois
    Schuchat, Anne
    Whitney, Cynthia G.
    PEDIATRICS, 2010, 126 (01) : E9 - E17
  • [30] Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008
    Moodley, Krishnee
    Coovadia, Yacoob Mahomed
    Cohen, Cheryl
    Meiring, Susan
    Lengana, Sarona
    De Gouveia, Linda
    von Mollendorf, Claire
    Crowther-Gibson, Penny
    Quan, Vanessa
    Eley, Brian
    Reubenson, Gary
    Nana, Trusha
    von Gottberg, Anne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (04) : 424 - 430